TYRA BIOSCIENCES INC TYRA
COM · Common Stock · CUSIP 90240B106
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersCarlsbad, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 41.8m as of 2022-04-30, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $10.70.
Trends to Q1 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2021 | 27 |
| Q4 2021 | 46 |
| Q1 2022 | 47 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2021 | 33 | 15 |
| Q1 2022 | 17 | 25 |
Biggest buyers
| Fairmount Funds Management LLC | Added | +639.6k |
| FMR LLC | Added | +621.3k |
| BVF INC/IL | Added | +599.0k |
| Sio Capital Management, LLC | New | +111.0k |
| JPMORGAN CHASE & CO | Added | +73.9k |
| STATE STREET CORP | Added | +72.7k |
| BANK OF AMERICA CORP /DE/ | Added | +58.4k |
| TCG Crossover Management, LLC | Added | +46.0k |
| RHUMBLINE ADVISERS | New | +11.7k |
| NEW YORK STATE COMMON RETIREMENT FUND | New | +10.5k |
Biggest sellers
| FRAZIER MANAGEMENT LLC | Sold out | -1.2m |
| PERCEPTIVE ADVISORS LLC | Reduced | -852.3k |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | -338.6k |
| JANUS HENDERSON GROUP PLC | Reduced | -257.3k |
| Logos Global Management LP | Reduced | -220.7k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -109.5k |
| Cormorant Asset Management, LP | Reduced | -82.5k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -61.7k |
| D. E. Shaw & Co., Inc. | Reduced | -44.4k |
| MORGAN STANLEY | Reduced | -34.2k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| RA CAPITAL MANAGEMENT, L.P. 13D · may seek influence -1.3 pts · filed 2026-09-17 | 19.9% |
| FMR LLC 13G · institution +11.2 pts · filed 2026-04-07 | 14.4% |
| JANUS HENDERSON GROUP PLC 13G · institution +1.8 pts · filed 2026-05-15 | 7.2% |
| Farallon Capital Partners, L.P. 13G · passive investor +1.0 pts · filed 2026-05-12 | 6.6% |
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor +2.1 pts · filed 2026-09-21 | 6.1% |
| NEXTECH VI ONCOLOGY SCSP 13G · passive investor filed 2026-08-14 | 6.0% |
| Paradigm Biocapital Advisors LP 13G · passive investor new · filed 2026-09-17 | 5.8% |
| TCG Crossover GP I, LLC 13G · passive investor new · filed 2025-03-06 | 5.7% |
Fell to 5% or below in the last year: BlackRock, Inc. (4.8%, 2026-10-27), FARALLON CAPITAL MANAGEMENT, L.L.C. (0.0%, 2026-08-14; now reported by Farallon Capital Partners, L.P.), Commodore Capital LP (4.2%, 2026-05-15), Harris Todd (4.8%, 2026-05-14), Canaan XI L.P. (1.4%, 2026-04-24)
Insider purchases and sales in Q1 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q2 2020 | 0 | — | 0 | — | — |
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 3 | $27.5m | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
None reported in Q1 2022.
Holders, Q1 2022
| Manager | Shares | Change |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. 1.69% of their portfolio | 7.2m $77.4m | Unchanged |
| Boxer Capital, LLC 3.55% of their portfolio | 6.4m $69.0m | Unchanged |
| Canaan Partners XI LLC 19.65% of their portfolio | 4.4m $47.2m | Unchanged |
| FMR LLC 0.00% of their portfolio | 4.1m $43.8m | Added +621.3k |
| Nextech Invest Ltd. 7.69% of their portfolio | 2.5m $26.9m | Unchanged |
| BVF INC/IL 1.06% of their portfolio | 2.5m $26.5m | Added +599.0k |
| Frazier Life Sciences Management, L.P. 1.21% of their portfolio | 1.3m $14.2m | First filing |
| Fairmount Funds Management LLC 3.25% of their portfolio | 1.3m $13.7m | Added +639.6k |
| JANUS HENDERSON GROUP PLC 0.00% of their portfolio | 909.2k $9.7m | Reduced -257.3k |
| TCG Crossover Management, LLC 3.85% of their portfolio | 896.4k $9.6m | Added +46.0k |
| Cormorant Asset Management, LP 0.62% of their portfolio | 757.4k $8.1m | Reduced -82.5k |
| BlackRock Inc. 0.00% of their portfolio | 583.2k $6.2m | Reduced -5.3k |
| VANGUARD GROUP INC 0.00% of their portfolio | 515.6k $5.5m | Reduced -846 |
| PERCEPTIVE ADVISORS LLC 0.11% of their portfolio | 494.4k $5.3m | Reduced -852.3k |
| Woodline Partners LP 0.05% of their portfolio | 266.2k $2.8m | Added +1.4k |
| Logos Global Management LP 0.35% of their portfolio | 252.7k $2.7m | Reduced -220.7k |
| WELLINGTON MANAGEMENT GROUP LLP 0.00% of their portfolio | 251.2k $2.7m | Reduced -338.6k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 228.5k $2.4m | Added +73.9k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 210.5k $2.3m | Added +4.2k |
| STATE STREET CORP 0.00% of their portfolio | 203.7k $2.2m | Added +72.7k |
| Ensign Peak Advisors, Inc 0.00% of their portfolio | 125.0k $1.3m | Unchanged |
| Sio Capital Management, LLC 0.48% of their portfolio | 111.0k $1.2m | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 100.1k $1.1m | Reduced -3.4k |
| D. E. Shaw & Co., Inc. 0.00% of their portfolio | 83.4k $893.0k | Reduced -44.4k |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 80.5k $861.0k | Added +1.1k |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 78.3k $838.0k | Reduced -4 |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 64.1k $686.0k | Added +58.4k |
| Bank of New York Mellon Corp 0.00% of their portfolio | 30.6k $328.0k | Added +10.0k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 29.3k $314.0k | Reduced -61.7k |
| Nuveen Asset Management, LLC 0.00% of their portfolio | 18.4k $197.0k | Unchanged |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 11.7k $125.0k | New |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 10.5k $113.0k | New |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 6.6k $71.0k | Reduced -776 |
| AMERICAN INTERNATIONAL GROUP, INC. 0.00% of their portfolio | 5.9k $63.0k | Reduced -606 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0.00% of their portfolio | 5.1k $54.0k | Reduced -1.6k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 2.6k $27.0k | Reduced -4.5k |
| BARCLAYS PLC 0.00% of their portfolio | 1.9k $20.0k | New |
| AMALGAMATED BANK 0.00% of their portfolio | 1.8k $19.0k | New |
| Amalgamated Financial Corp. 0.00% of their portfolio | 1.8k $19.0k | First filing |
| UBS Group AG 0.00% of their portfolio | 1.7k $19.0k | Reduced -3.7k |
| MORGAN STANLEY 0.00% of their portfolio | 1.6k $16.0k | Reduced -34.2k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 1.2k $13.0k | Added +280 |
| Legal & General Group Plc 0.00% of their portfolio | 1.1k $12.0k | Unchanged |
| Ameritas Investment Partners, Inc. 0.00% of their portfolio | 940 $10.0k | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 725 $8.0k | Reduced -1.8k |
| CITIGROUP INC 0.00% of their portfolio | 459 $5.0k | Reduced -2.7k |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |